This systematic review, conducted by researchers from the Beijing University of Chinese Medicine and the University of Chicago, analyzed data from 76 studies to assess the safety and efficacy of fifteen glucagon-like peptide-1 (GLP-1) receptor agonists used in the treatment of type 2 diabetes
An analysis of body-focused repetitive behaviors in people with hair-pulling
At higher doses (1.72.0 mg), some patients lose 1015% of body weight over a year
Since its inception more than 50 years ago, BrightFocus and its flagship research programsAlzheimers Disease Research, Macular Degeneration Research, and National Glaucoma Researchhas awarded more than $330 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools
There are a lot of layers to it
Typically, this isnt a cause for concern, but when in doubt, contact us for guidance